[go: up one dir, main page]

DK2062053T3 - Forbedret immunoanalysefremgangsmåde - Google Patents

Forbedret immunoanalysefremgangsmåde

Info

Publication number
DK2062053T3
DK2062053T3 DK07804276.9T DK07804276T DK2062053T3 DK 2062053 T3 DK2062053 T3 DK 2062053T3 DK 07804276 T DK07804276 T DK 07804276T DK 2062053 T3 DK2062053 T3 DK 2062053T3
Authority
DK
Denmark
Prior art keywords
immunoassay method
improved immunoassay
improved
immunoassay
Prior art date
Application number
DK07804276.9T
Other languages
English (en)
Inventor
John Forsyth Russell Robertson
Andrea Murray
Caroline Chapman
Tony Barnes
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Priority claimed from PCT/GB2007/003486 external-priority patent/WO2008032084A1/en
Application granted granted Critical
Publication of DK2062053T3 publication Critical patent/DK2062053T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
DK07804276.9T 2006-09-13 2007-09-12 Forbedret immunoanalysefremgangsmåde DK2062053T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84415806P 2006-09-13 2006-09-13
GB0618055A GB2441824A (en) 2006-09-13 2006-09-13 Immunoassay method
PCT/GB2007/003486 WO2008032084A1 (en) 2006-09-13 2007-09-12 Improved immunoassay methods

Publications (1)

Publication Number Publication Date
DK2062053T3 true DK2062053T3 (da) 2013-03-04

Family

ID=37309880

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07804276.9T DK2062053T3 (da) 2006-09-13 2007-09-12 Forbedret immunoanalysefremgangsmåde
DK11183188.9T DK2444812T3 (da) 2006-09-13 2007-09-12 Forbedret immunoassayfremgangsmåder

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11183188.9T DK2444812T3 (da) 2006-09-13 2007-09-12 Forbedret immunoassayfremgangsmåder

Country Status (9)

Country Link
EP (1) EP2444812B1 (da)
CN (1) CN103257227B (da)
BR (1) BRPI0716720A2 (da)
DK (2) DK2062053T3 (da)
ES (2) ES2397979T3 (da)
GB (1) GB2441824A (da)
PT (2) PT2444812E (da)
SG (1) SG174803A1 (da)
SI (1) SI2062053T1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105229470B (zh) * 2013-03-15 2018-11-27 艾克斯肯诊断股份有限公司 用于治疗和诊断系统性红斑狼疮的方法
CN103969453B (zh) * 2014-05-30 2016-07-06 苏州工业园区为真生物医药科技有限公司 甲胎蛋白自身抗体单独或与甲胎蛋白联合作为肿瘤诊断、疗效评估和复发监控标志物的应用
CN111413498B (zh) * 2020-04-08 2023-08-04 复旦大学附属中山医院 一种肝细胞肝癌的自身抗体7-AAb检测panel及其应用
CN116519936A (zh) * 2023-02-28 2023-08-01 杭州凯保罗生物科技有限公司 用于前列腺癌早期检测的肿瘤自身抗原/抗体组合及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
AUPP349098A0 (en) 1998-05-13 1998-06-04 South Eastern Sydney Area Health Service A method of monitoring pancreatic tissue viability
GB2424273B (en) 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
CN1525170A (zh) * 2003-09-15 2004-09-01 南京农业大学 检测猪繁殖与呼吸综合征抗体的elisa试剂盒及用法
CN1766620A (zh) * 2005-10-13 2006-05-03 南京农业大学 检测猪日本脑炎抗体的重组e蛋白elisa试剂盒
CN1804629A (zh) * 2005-12-01 2006-07-19 南京农业大学 检测猪圆环病毒2型抗体的试剂盒
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法

Also Published As

Publication number Publication date
GB2441824A (en) 2008-03-19
EP2444812A3 (en) 2012-05-09
SG174803A1 (en) 2011-10-28
BRPI0716720A2 (pt) 2013-09-03
CN103257227B (zh) 2015-12-02
CN103257227A (zh) 2013-08-21
ES2397979T3 (es) 2013-03-12
DK2444812T3 (da) 2016-01-11
SI2062053T1 (sl) 2013-03-29
EP2444812A2 (en) 2012-04-25
PT2444812E (pt) 2016-03-11
EP2444812B1 (en) 2015-12-02
PT2062053E (pt) 2013-02-11
ES2556360T3 (es) 2016-01-15
GB0618055D0 (en) 2006-10-25

Similar Documents

Publication Publication Date Title
SE0701325L (sv) Metod
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
DE602006019782D1 (de) Kapselperforationsmodul
BRPI0716500A2 (pt) Projétil e método de direcionamento de projétil
AT504580A3 (de) Scan-einrichtung
EP2089722A4 (en) BIOMARKERS
DE602007008787D1 (de) Spannvorrichtung
DE602006019150D1 (de) Riemenscheibenanorndung
ATE546437T1 (de) Aminomethyl-4-imidazole
DE502007000218D1 (de) nsetzungen
DE502007001629D1 (de) Rfahren
DE502007002453D1 (de) Kunstoffverdichtergehäuse
DE602006016174D1 (de) Blisterverpackungsverfahren
FI20065363A0 (fi) Erotusmenetelmä
DE112007001674A5 (de) Spannvorrichtung
DE502007000361D1 (de) Stanznieteinheit
DE102006045567A8 (de) Crimpstabilisierung
DE112007003147A5 (de) Rohr-Biegevorrichtung
DE502007001652D1 (de) Notöltank
DE502007005975D1 (de) Wischblatt
DE602006015328D1 (de) Abtastfehlerkompensation
BRPI0719956A2 (pt) Radiofluoração
DE502007006319D1 (de) Staubabsaugadaptervorrichtung